Sensorineural Hearing Loss After Treatment of Nasopharyngeal Carcinoma: A Longitudinal Analysis

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 5, 2009, Pages 1335-1342

  Chan, S H ^a   Ng, W T ^a   Kam, K L ^a   Lee, Michael C H ^a   Choi, C W ^a   Yau, T K ^a   Lee, Anne W M ^a   Chow, S K ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Chemoradiotherapy; Dose constraint; Nasopharyngeal carcinoma; Prognostic factors; Sensorineural hearing loss

Indexed keywords

AUDITION; CHEMOTHERAPY; THREE DIMENSIONAL;

CHEMORADIOTHERAPY; DOSE CONSTRAINT; NASOPHARYNGEAL CARCINOMA; PROGNOSTIC FACTORS; SENSORINEURAL HEARING LOSS;

PLATINUM COMPOUNDS;

CARBOPLATIN; CISPLATIN; FLUOROURACIL; PLATINUM DERIVATIVE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ASSESSMENT; COCHLEA; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; RADIATION DOSE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TYMPANOMETRY;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COCHLEA; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HEARING LOSS, SENSORINEURAL; HUMANS; LONGITUDINAL STUDIES; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; TUMOR BURDEN; YOUNG ADULT;

EID: 62649131170     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.07.034     Document Type: Article

References (25)

1. Leach W. Irradiation of the ear. J Laryngol Otol 79 (1965) 870-880
2. Hoistad D.L., Ondrey F.G., Mutlu C., et al. Histopathology of human temporal bone after cis-platinum, radiation, or both. Otolaryngol Head Neck Surg 118 (1998) 825-832
3. Al-Sarraf M., LeBlanc M., Giri P.G., et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 16 (1998) 1310-1317
4. Lee A.W., Lau W.H., Tung S.Y., et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 23 (2005) 6966-6975
5. Wee J., Tan E.H., Tai B.C., et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 23 (2005) 6730-6738
6. Lin J.C., Jan J.S., Hsu C.Y., et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival. J Clin Oncol 21 (2003) 631-637
7. Chan A.T., Leung S.F., Ngan R.K., et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 97 (2005) 536-539
8. Lee A.W., Yau T.K., Wong D.H., et al. Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation. Int J Radiat Oncol Biol Phys 63 (2005) 1331-1338
9. Ng W.T., Chan S.H., Lee A.W., et al. Parapharyngeal extension of nasopharyngeal carcinoma: Still a significant factor in era of modern radiotherapy?. Int J Radiat Oncol Biol Phys 72 (2008) 1082-1089
10. Lee A.W.M., Perez C.A., Law S.C.K., et al. Nasopharynx. In: Halperin E.C., Perez C.A., and Brady L.W. (Eds). Principles and practice of radiation oncology. 5th ed. (2008), Lippincott Williams & Wilkins, Philadelphia 820-857
11. Kwong D.L., Wei W.I., Sham J.S., et al. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: A prospective study of the effect of radiation and cisplatin treatment. Int J Radiat Oncol Biol Phys 36 (1996) 281-289
12. Honore H.B., Bentzen S.M., Moller K., et al. Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: Individualized risk estimation. Radiother Oncol 65 (2002) 9-16
13. Bentzen S.M., and Tucker S.L. Quantifying the position and steepness of radiation dose-response curves. Int J Radiat Biol 71 (1997) 531-542
14. Oh Y.T., Kim C.H., Choi J.H., et al. Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma. Radiother Oncol 72 (2004) 79-82
15. Chen W.C., Jackson A., Budnick A.S., et al. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer 106 (2006) 820-829
16. Low W.K., Toh S.T., Wee J., et al. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: A single, blinded, randomized study. J Clin Oncol 24 (2006) 1904-1909
17. Grau C., Moller K., Overgaard M., et al. Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 21 (1991) 723-728
18. Pan C.C., Eisbruch A., Lee J.S., et al. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 61 (2005) 1393-1402
19. Bhandare N., Antonelli P.J., Morris C.G., et al. Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys 67 (2007) 469-479
20. Raaijmakers E., and Engelen A.M. Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation? A systematic review of the literature. Radiother Oncol 65 (2002) 1-7
21. Taylor I., and Taylor M.M. Psycholinguistics-Learning and using languages (1990), Prentice Hall, London
22. Hornsby B.W., and Ricketts T.A. The effects of hearing loss on the contribution of high- and low-frequency speech information to speech understanding. II. Sloping hearing loss. J Acoust Soc Am 119 (2006) 1752-1763
23. Hornsby B.W., and Ricketts T.A. The effects of hearing loss on the contribution of high- and low-frequency speech information to speech understanding. J Acoust Soc Am 113 (2003) 1706-1717
24. Kam M.K., Teo P.M., Chau R.M., et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience. Int J Radiat Oncol Biol Phys 60 (2004) 1440-1450
25. Teo P.M., Leung S.F., Tung S.Y., et al. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: A study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG). Radiother Oncol 79 (2006) 27-33